1. Home
  2. MNKD vs WEN Comparison

MNKD vs WEN Comparison

Compare MNKD & WEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$5.68

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo Wendy's Company (The)

WEN

Wendy's Company (The)

HOLD

Current Price

$8.36

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNKD
WEN
Founded
1991
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.6B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
MNKD
WEN
Price
$5.68
$8.36
Analyst Decision
Strong Buy
Hold
Analyst Count
6
21
Target Price
$10.08
$10.42
AVG Volume (30 Days)
3.3M
5.8M
Earning Date
11-05-2025
02-12-2026
Dividend Yield
N/A
6.72%
EPS Growth
23.47
0.63
EPS
0.10
0.95
Revenue
$313,787,000.00
$2,208,190,000.00
Revenue This Year
$21.54
N/A
Revenue Next Year
$22.21
$3.06
P/E Ratio
$57.92
$8.81
Revenue Growth
17.43
N/A
52 Week Low
$3.38
$7.83
52 Week High
$6.68
$16.48

Technical Indicators

Market Signals
Indicator
MNKD
WEN
Relative Strength Index (RSI) 48.22 48.93
Support Level $5.56 $8.17
Resistance Level $6.12 $8.41
Average True Range (ATR) 0.17 0.22
MACD -0.04 0.01
Stochastic Oscillator 20.51 34.46

Price Performance

Historical Comparison
MNKD
WEN

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About WEN Wendy's Company (The)

The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $12.6 billion in 2024, narrowly edging Burger King ($11.5 billion) and clocking in well behind wide-moat McDonald's ($51.1 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spanned more than 7,200 total stores in 30 countries as of year-end 2024. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for roughly 94% of stores, and through franchise flipping and advisory fees.

Share on Social Networks: